Reuters - The following is a summary of the recent studies on COVID 19. They include research that warrants further study to verify the findings and have yet to be certified by peer review.
The mRNA vaccine from Moderna Inc induces higher levels of antibodies against the coronavirus that causes COVID – 19 than the similar vaccine from Pfizer Inc and partner BioNTech SE, Belgian researchers have found, although what this means for their efficacy is not clear. Soon after receiving their second shot, the 688 healthcare workers who got Moderna's vaccine had antibody levels roughly twice as high as the 959 who received Pfizer BioNTech product, regardless of their ages, from doctors at a Belgian medical center reported. This held true even after accounting for individual risk factors, and regardless of whether participants had previously been infected with the virus, the researchers reported in JAMA: bit.ly 38 wJcdI on Monday. Is there any extra-chrome element in antibodies that contain just a component? com business mrna-vaccines-trigger - biosecurity-increase response -some, cancer-resistant drugs - might-h elp - 2021 08 - 25 of the immune system's defenses, however. The study can not determine whether one vaccine is more effective at preventing infection or illness, or whether antibodies induced stay longer in the blood before disappearing. Those questions, and others, require further investigation, the researchers said.
In severe illness and arthritis drug adds to benefits of steroids.
Hospitalized COVID - 19 patients died less often if they received Eli Lilly and Co's rheumatoid arthritis drug baricitinib along with the other treatments their doctors had prescribed, according to a study published on Wednesday in The Lancet Respiratory Medicine https: bit.ly 38 vos 5 Z. The randomized trial involved 1,525 seriously ill patients, all of whom needed oxygen to help with breathing. More than 90% were already receiving generic dexamethasone, a generic drug known to improve survival of critically ill COVID-19 patients. Though baricitinib sold under the brand name Olumiant did not make patients more sick, it did reduce their risk of dying. The 28 Day and 60 Day Death Rates were significantly lower among patients randomly assigned to receive baricitinib instead of a placebo. Baricitinib is already approved in the United States for use in hospitalized COVID - 19 patients in combination with Gilead Science's antiviral drug Remdesivir. The two drugs together appear to have more benefit https: www.reuters.com. com article us-health coronavirus science fl u-outbreaks may-be - linked - to - arthritis-19 - arthritis-drug - benefit-see n-idUSKBN 26538 P than remdesivir alone. In the new study, more than 80% of participants were not receiving remdesivir, suggesting that baricitinib also has synergistic effects with other standard of care treatments, including dexamethasone, researchers said.
The COVID-19 vaccine for sensitive people is safe, and all allergic adults can safely sneeze at Pfizer BioNTech, according to a new study. Among the 8,102 patients with allergies in the Israeli study, 95% received the shots in routine settings because their risk of a severe allergic reaction to the vaccine was low and no such reactions were reported. The remaining 429 patients, considered to be highly allergic, received the vaccines under careful supervision and were observed for two hours thereafter. Nine had allergic reactions, including three who showed an potentially life-threatening anaphylaxis. All of the patients responded to treatment with epinephrine and no one had to be hospitalized, according to a report published on Tuesday in JAMA Network Open https: bit.ly 2 WJJzid. An editorial https: bit.ly 3 zAXHsJ from the study said lessons from this study of general allergic reactions to the Moderna vaccine are likely allergic to the Pfizer vaccine as well, stated.